nanobot

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

by Gyöngyösi MLang IDettke MBeran GGräf SSochor HNyolczas NCharwat SHemetsberger RChrist GÉdes IBalogh LKrause KTJaquet KKuck KHBenedek IHintea TheodoraKiss RPréda IKotevski VPejkov HZamini SKhorsand ASodeck GKaider AMaurer GGlogar D

Nature Clinical Practice Cardiovascular Medicine, 2009

6(1):70-81. ISSN 1743-4297 (Print), ISSN: 1743-4297(web). FI 5,902

Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction

by Nyolczas NGyöngyösi MBeran GDettke MGraf SSochor HChrist GEdes IBalogh LKrause KTJaquet KKuck KHBenedek IHintea TKiss RPréda IKotevski VPejkov HDudek DHeba GSylven CCharwat SJacob RMaurer GLang IGlogar D

American Heart Journal, 2007

153(2):212.e1-7, ISSN 0002-8703. FI 3,649

Altered nutritional status, inflammation and systemic vulnerability in patients with acute myocardial infarction undergoing percutaneous coronary revascularisation: A prospective study in a level 3 cardiac critical care unit

by Victoria A RusMonica ChituSimona Cernea, Imre Benedek, Roxana HodasRamona ZavateTiberiu NyulasMarian HinteaTheodora Benedek

Nutrition & Dietetics, 2020

2020;77(2):212‐222. doi:10.1111/1747-0080.12536 FI 1,339

Impact of inflammation-mediated response on pan-coronary plaque vulnerability, myocardial viability and ventricular remodeling in the postinfarction period – the VIABILITY study: Protocol for a non-randomized prospective clinical study

by Mirabela MorariuRoxana HodasTheodora BenedekImre BenedekDiana OpincariuAndras MesterMonica ChituIstvan KovacsCiprian RezusDan PasaroiuNoemi MitraSándor M SzilágyiDan GeorgescuElena Rezus

Medicine (Baltimore), 2019

98(17):e15194. doi:10.1097/MD.0000000000015194. FI 1,87